Cell-cycle arrest biomarkers: the light at the end of the acute kidney injury tunnel

patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol 2012; 7: 1964–1968 15. Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986–987 16. JohnsonWJ, Kyle RA, PinedaAA et al. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990; 150: 863–869 17. Pasquali S, Zucchelli P, Casanova S et al. Renal histological lesions and clinical syndromes in multiplemyeloma. Renal Immunopathology Group. Clin Nephrol 1987; 27: 222–228 18. Pozzi C, Pasquali S, Donini U et al. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italian Renal Immunopathology Group. Clin Nephrol 1987; 28: 1–9 19. Fish R, Pinney J, Jain P et al. The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol 2010; 5: 1977–1980 20. Soares SM, Fervenza FC, Lager DJ et al. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: singlecenter experience in 101 patients. Am J Kidney Dis 2008; 52: 1079–1083